The Receptor for Advanced Glycation End Products (RAGE) Is Elevated in Women with Preeclampsia

References

• Hubel C A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999; 222(3)222–235
   PubMed Web of Science ®Google Scholar
• Myatt L, Rosenfield R B, Eis A L, Brockman D E, Greer I, Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 1996; 28(3)488–493
   Google Scholar
• Roggensack A M, Zhang Y, Davidge S T. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 1999; 33(1)83–89
   PubMedGoogle Scholar
• Wang Y, Walsh S W. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig 1996; 3(4)179–184
   Google Scholar
• Davidge S T, Hubel C A, Brayden R D, Capeless E C, McLaughlin M K. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol 1992; 79(6)897–901
   PubMed Web of Science ®Google Scholar
• Wang Y, Walsh S W, Kay H H. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol 1992; 167(4 Pt 1)946–949
   PubMed Web of Science ®Google Scholar
• Mellembakken J R, Hogasen K, Mollnes T E, Hack C E, Abyholm T, Videm V. Increased systemic activation of neutrophils but not complement in preeclampsia. Obstet Gynecol 2001; 97(3)371–374
   Google Scholar
• Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995; 46: 223–234
   PubMed Web of Science ®Google Scholar
• Neeper M, Schmidt A M, Brett J, Yan S D, Wang F, Pan Y C, Elliston K, Stern D, Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992; 267(21)14998–15004
   PubMed Web of Science ®Google Scholar
• Li J, Schmidt A M. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 1997; 272(26)16498–16506
   Google Scholar
• Schmidt A M, Hofmann M, Taguchi A, Yan S D, Stern D M. RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation. Semin Thromb Hemost 2000; 26(5)485–493
   PubMed Web of Science ®Google Scholar
• Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor‐alpha through nuclear factor‐kappa B, and by 17beta‐estradiol through Sp‐1 in human vascular endothelial cells. J Biol Chem 2000; 275(33)25781–25790
   Google Scholar
• Miyata T, Hori O, Zhang J, Yan S D, Ferran L, Iida Y, Schmidt A M. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE‐beta2microglobulin with human mononuclear phagocytes via an oxidant‐sensitive pathway. Implications for the pathogenesis of dialysis‐related amyloidosis. J Clin Invest 1996; 98(5)1088–1094
   PubMed Web of Science ®Google Scholar
• Quehenberger P, Bierhaus A, Fasching P, Muellner C, Klevesath M, Hong M, Stier G, Sattler M, Schleicher E, Speiser W, Nawroth P P. Endothelin 1 transcription is controlled by nuclear factor‐kappaB in AGE‐stimulated cultured endothelial cells. Diabetes 2000; 49(9)1561–1570
   PubMed Web of Science ®Google Scholar
• Williams M A, Mahomed K, Farrand A, Woelk G B, Mudzamiri S, Madzime S, King I B, McDonald G B. Plasma tumor necrosis factor‐alpha soluble receptor p55 (sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean women. J Reprod Immunol 1998; 40(2)159–173
   Google Scholar
• Shaarawy M, Abdel‐Magid A M. Plasma endothelin‐1 and mean arterial pressure in the prediction of pre‐eclampsia. Int J Gynaecol Obstet 2000; 68(2)105–111
   Google Scholar
• Catalano P M, Tyzbir E D, Roman N M, Amini S B, Sims E A. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 1991; 165(6 Pt 1)1667–1672
   PubMed Web of Science ®Google Scholar
• Schmidt A M, Hori O, Cao R, Yan S D, Brett J, Wautier J L, Ogawa S, Kuwabara K, Matsumoto M, Stern D. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 1996; 45(Suppl 3)S77–S80
   Google Scholar
• Schmidt A M, Stern D. Atherosclerosis and diabetes: the RAGE connection. Curr Atheroscler Rep 2000; 2(5)430–436
   PubMedGoogle Scholar
• Bierhaus A, Ritz E, Nawroth P P. Expression of receptors for advanced glycation end‐products in occlusive vascular and renal disease. Nephrol Dial Transplant 1996; 11(Suppl 5)87–90
   Google Scholar
• Najemnik C, Sinzinger H, Kritz H. Endothelial dysfunction, atherosclerosis and diabetes. Acta Med Austriaca 1999; 26(5)148–153
   Google Scholar
• Ashworth J R, Warren A Y, Baker P N, Johnson I R. Loss of endothelium‐dependent relaxation in myometrial resistance arteries in pre‐eclampsia. Br J Obstet Gynaecol 1997; 104(10)1152–1158
   PubMedGoogle Scholar
• Yamagishi S, Fujimori H, Yonekura H, Yamamoto Y, Yamamoto H. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor‐1 in human microvascular endothelial cells. Diabetologia 1998; 41(12)1435–1441
   Google Scholar
• Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis A P. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 1998; 101(6)1219–1224
   PubMed Web of Science ®Google Scholar
• Wautier J L, Zoukourian C, Chappey O, Wautier M P, Guillausseau P J, Cao R, Hori O, Stern D, Schmidt A M. Receptor‐mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 1996; 97(1)238–243
   Web of Science ®Google Scholar
• Shaarawy M, Didy H E. Thrombomodulin, plasminogen activator inhibitor type 1 (PAI‐1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia. Int J Gynaecol Obstet 1996; 55(2)135–139
   Google Scholar
• Takacs P, Kauma S W, Sholley M M, Walsh S W, Dinsmoor M J, Green K. Increased circulating lipid peroxides in severe preeclampsia activate NF‐kappaB and upregulate ICAM‐1 in vascular endothelial cells. Faseb J 2001; 15(2)279–281
   PubMed Web of Science ®Google Scholar
• Bosio P M, Wheeler T, Anthony F, Conroy R, O'Herlihy C, McKenna P. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am J Obstet Gynecol 2001; 184(2)146–152
   PubMed Web of Science ®Google Scholar
• Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran L J, Jr., Taguchi A, Olson K, Bucciarelli L, Goova M, Hofmann M A, Cataldegirmen G, D'Agati V, Pischetsrieder M, Stern D M, Schmidt A M. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E‐null mice. Arterioscler Thromb Vasc Biol 2001; 21(6)905–910
   Google Scholar
• Schmidt A M, Hori O, Chen J X, Li J F, Crandall J, Zhang J, Cao R, Yan S D, Brett J, Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule‐1 (VCAM‐1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995; 96(3)1395–1403
   PubMed Web of Science ®Google Scholar
• Redman C W, Sargent I L. The pathogenesis of pre‐eclampsia. Gynecol Obstet Fertil 2001; 29(7–8)518–522
   PubMedGoogle Scholar
• Faas M M, Schuiling G A. Pre‐eclampsia and the inflammatory response. Eur J Obstet Gynecol Reprod Biol 2001; 95(2)213–217
   Google Scholar
• Wang Y, Gu Y, Philibert L, Lucas M J. Neutrophil activation induced by placental factors in normal and pre‐eclamptic pregnancies in vitro. Placenta 2001; 22(6)560–565
   PubMed Web of Science ®Google Scholar
• Fickling S A, Whitley G S, Nussey S S. The cell adhesion molecule, VCAM‐1, is selectively elevated in serum in pre‐eclampsia: does this indicate the mechanism of leucocyte activation?. Br J Obstet Gynaecol 1995; 102(2)173–174
   PubMedGoogle Scholar